HCA Hospitals Challenge Underpayments by Self-Funded Plan

We served as lead counsel for several HCA hospitals against a self-funded employee benefit plan for underpaying hundreds of claims contrary to the agreed fee schedule with a focus on ERISA preemption issues.

HCA Holdings, Inc. (NYSE: HCA) owns and operates hospitals and freestanding surgery centers in the U.S. and in London, England.

You Also May Be Interested In:

  • We serve as lead counsel for the company and 23 individual defendants in a putative class action alleging violations of Sections 10(b), 10A and 20(a) of the Securities Exchange Act of 1934 and Sections 11, 12 and 15 of the Securities Act of 1933. The plaintiffs allege that defendants made materially false and misleading statements and omissions concerning the company’s contracts and its out-of-network billing. In re Envision Healthcare Corporation Securities Litigation, Civil Action No. 3:17-cv-01112 (M.D. Tenn.).

    We serve as lead counsel for the company and 23 individual defendants in a putative class action alleging violations of...
    Client Type: Private Company
  • We served as lead counsel for Envision Healthcare Corporation and current and former board members in four derivative actions asserting claims for breach of fiduciary duty, wasted corporate assets, unjust enrichment and violations of the Securities and Exchange Act of 1934 arising out of allegations of over billing and improperly billing medical patients, failing to supervise corporate action and failure to maintain proper internal controls.  These cases were consolidated in 2018.  Following a company merger, the case was dismissed in its entirety on October 25, 2018. Purrone v. Sanger et al., Case No. 3:17-cv-01472 (M.D. Tenn.).

    We served as lead counsel for Envision Healthcare Corporation and current and former board members in four derivative actions asserting...
    Client Type: Private Company
  • Represented Quest Diagnostics in its acquisition of the Outreach Laboratory Service Operations of Marin General Hospital

    We represented Quest Diagnostics (NYSE: DGX) in its acquisition of the outreach laboratory services operations of Marin General Hospital, a non-profit, full-service...
    Client Type: Public Company